Vesigen Therapeutics, Inc.

Vesigen Therapeutics, Inc.

Biotechnology Research

Cambridge, Massachusetts 4,625 followers

Delivering intracellular therapeutics with ARMMed microvesicles

About us

Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets. Our team is committed to leveraging ARMMs technology to enable new therapies and address currently unmet medical needs.

Website
https://www.vesigen.com/
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Cambridge, Massachusetts
Type
Privately Held

Locations

  • Primary

    790 Memorial Dr

    Suite 103

    Cambridge, Massachusetts 02139, US

    Get directions

Employees at Vesigen Therapeutics, Inc.

Updates

Similar pages

Browse jobs

Funding

Vesigen Therapeutics, Inc. 2 total rounds

Last Round

Grant

Investors

FARA
See more info on crunchbase